for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Blackmores Limited

BKL.AX

Latest Trade

80.00AUD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

59.84

 - 

95.68

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
80.00
Open
--
Volume
--
3M AVG Volume
1.71
Today's High
--
Today's Low
--
52 Week High
95.68
52 Week Low
59.84
Shares Out (MIL)
18.68
Market Cap (MIL)
1,519.38
Forward P/E
44.25
Dividend (Yield %)
0.89

Next Event

Half Year 2021 Blackmores Ltd Earnings Release

Latest Developments

更多

Blackmores Sees H1 FY21 Net Sales Growth In Mid-Single Digits Range

Blackmores Divests Global Therapeutics To Mcpherson's Ltd

Blackmores Says Anne Templeman-Jones To Succeed Brent Wallace As Chairman

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Blackmores Limited

Blackmores Limited is an Australia-based company that is engaged in the development, sales and marketing of health products for humans and animals, including vitamins, herbal and mineral nutritional supplements. The Company's segments include ANZ, China, BioCeuticals Group and international. The Company’s brands include Blackmores- a natural health brand; BioCeuticals - a practitioner range; Impromy - its pharmacy based weight management program developed in collaboration with the Commonwealth Scientific and Industrial Research Organization (CSIRO), and Pure Animal Wellbeing - natural health products for pets.

Industry

Biotechnology & Drugs

Contact Info

20 Jubilee Ave

SYDNEY, NSW

2102

Australia

+61.8.00608511

https://www.blackmores.com.au/

Executive Leadership

Alastair Symington

Chief Executive Officer, Managing Director, Executive Director

Gunther Burghardt

Group Chief Financial Officer

Jeremy Cowan

Chief Operations Officer

Jane Franks

Chief People Officer

Brett Winn

Chief Information Officer

Key Stats

3.11 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, AUD)

2018

0.6K

2019

0.6K

2020

0.6K

2021(E)

0.6K
EPS (AUD)

2018

4.057

2019

3.092

2020

1.035

2021(E)

1.775
Price To Earnings (TTM)
89.91
Price To Sales (TTM)
2.67
Price To Book (MRQ)
4.80
Price To Cash Flow (TTM)
40.68
Total Debt To Equity (MRQ)
36.95
LT Debt To Equity (MRQ)
34.60
Return on Investment (TTM)
4.20
Return on Equity (TTM)
3.05

Latest News

Latest News

UPDATE 2-Australia's Blackmores scraps dividend, to cut 10% jobs as virus hits profit

Australian vitamin maker Blackmores Ltd on Tuesday scrapped its final dividend and said it would cut around 100 jobs after a two-third drop in annual profit, as sales in China, its biggest overseas market, were hit by the coronavirus outbreak.

Australia's Blackmores annual profit tanks on virus hit

Australia's Blackmores Ltd on Tuesday scrapped its final dividend and reported a 66.2% slump in full-year profit as the coronavirus crisis disrupted the vitamin maker's supply chain and hit sales to China.

UPDATE 2-Australia's Blackmores hires China-focused boss to lead turnaround

* Shares lift 1.9% to one-week high (Recasts adding market reaction, quotes from analyst and management)

Vitamin maker Blackmores' nine-month profit drops 14.3 percent

Australian vitamin maker Blackmores Ltd on Tuesday reported a 14.3 percent fall in net profit for the first nine months, as the company continues to grapple with softening demand from its largest Asian market, China.

UPDATE 3-Vitamin maker Blackmores sounds alarm on China demand health, shares hammered

* Shares mark biggest daily percentage drop since 1985 listing (Recasts on China review, updates shares)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up